期刊文献+

血清肿瘤标志物检测在判断卵巢恶性肿瘤术后复发中的应用价值

The Application Value of Serum Tumor Markers in Judging the Recurrence of Ovarian Malignant Tumor After Operation
下载PDF
导出
摘要 目的研究血清肿瘤标志物检测在判断卵巢恶性肿瘤术后复发中的应用价值。方法选取我院收治的54例卵巢恶性肿瘤患者作为观察组,选取同期体检的54例健康人员作为对照组。检测两组血清肿瘤标志物水平。结果观察组LPA、CA125、TSGF血清肿瘤标志物水平均显著高于对照组(P<0.05);血清肿瘤标志物中最具有诊断价值的是TSGF,其次是CA125,最后为LPA。结论血清肿瘤标志物检测在判断卵巢恶性肿瘤术后复发中的效果良好,LPA、CA125、TSGF均有显著上升,可用于临床上诊断卵巢恶性肿瘤复发的有效指标。 Objective To study the value of serum tumor markers in judging the recurrence of ovarian malignant tumor after operation. Methods Fifty-four cases of ovarian malignant tumor in our hospital were selected as observation group,and 54 healthy persons were selected as control group at the same time. The levels of serum tumor markers were compared in the two groups. Results The serum tumor markers of LPA,CA125 and TSGF in the observation group were significantly higher than those in the control group(P<0.05). The most valuable diagnostic value in the serum tumor markers was TSGF,followed by CA125,and finally LPA. Conclusion The detection of serum tumor markers has a good effect in predicting postoperative recurrence of ovarian malignancies,and LPA,CA125 and TSGF have increased significantly,which can be used for clinical diagnosis of ovarian cancer recurrence.
作者 李宗铭
机构地区 德阳市人民医院
出处 《大医生》 2017年第8期91-92,共2页 Doctor
关键词 血清肿瘤标志物 卵巢 恶性肿瘤 serum tumor markers ovary malignant tumor
  • 相关文献

参考文献3

二级参考文献36

  • 1邱大鹏,韩风,聂常富,周进学,蒙博.AFP-L3和AFP mRNA联合检测在肝癌治疗疗效观察和预后中的作用[J].中国老年学杂志,2014,34(10):2637-2638. 被引量:6
  • 2梁文通,彭丽珊.联合辅助检查对诊断卵巢恶性肿瘤的价值[J].遵义医学院学报,2005,28(3):266-268. 被引量:1
  • 3梁英魁,郭勇,张燕群,郑奎宏,姜丽,李小娟.CT和血清肿瘤标记物在卵巢癌诊断和分期中的应用[J].中国医学影像学杂志,2006,14(2):87-91. 被引量:7
  • 4Hellstrom I,Raycraft J,Hayden-Ledbetter M,et al.The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma[].Cancer Research.2003
  • 5Kupesic S,Vujisic S,Kurjak A,et al.Preoperative assessment of ovarian tumors by CA125 measurement and transvaginal color Doppler ultrasound[].Acta Medica Croatica.2002
  • 6Maeda T,Inoue M,Koshiba S,et al.Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125(MUC16)[].Journal of Biological Chemistry.2004
  • 7Jemal A, BrayF, MelissaM, etal. Global Cancer Statistics[J].Ca Cancer J Clin, 2011, 6 1(2) : 69-90.
  • 8Thomas TT, Ruscher Kr, Mandavilli S, et al. Ovarian steroid cell tumor, not otherwise specified, associated with congenital adrenal hyperplasia: rare tumors of an endocrine disease [J] . Pediatr Surg, 2013, 48(6) : e23-e27.
  • 9Hellstrom I, Raycraft J, Hayden-Ledbetter M, et al. The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma[J].CancerRes, 2003, 63(13): 3695-3700..
  • 10Ferraro S,Braga F,Lanzoni M,et al. Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarion cancer diagnosis:a systematic review EJ] ~ ClinPathol,2013,66 (4) :273-281.

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部